Total Payments
$976.79
2021 Payments
$164.29
Companies
8
Transactions
22
Medicare Patients
2,329
Medicare Billing
$108,055
Payment Breakdown by Category
Food & Beverage$962.90 (98.6%)
Education$13.89 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $962.90 | 21 | 98.6% |
| Education | $13.89 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $299.12 | 6 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $287.28 | 4 | $0 (2021) |
| Genentech USA, Inc. | $170.72 | 2 | $0 (2019) |
| Allergan Inc. | $67.27 | 1 | $0 (2018) |
| Fisher & Paykel Healthcare Inc | $59.61 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $47.51 | 3 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $33.27 | 4 | $0 (2019) |
| Grifols USA, LLC | $12.01 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $164.29 | 6 | AstraZeneca Pharmaceuticals LP ($108.83) |
| 2020 | $82.86 | 2 | AstraZeneca Pharmaceuticals LP ($70.85) |
| 2019 | $330.82 | 8 | GlaxoSmithKline, LLC. ($182.76) |
| 2018 | $205.96 | 3 | GlaxoSmithKline, LLC. ($79.08) |
| 2017 | $192.86 | 3 | AstraZeneca Pharmaceuticals LP ($107.60) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $90.46 | General |
| 04/21/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Respiratory | ||||||
| 03/11/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: RESPIRATORY | ||||||
| 02/11/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $70.85 | General |
| Category: Respiratory | ||||||
| 05/01/2020 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Pulmonology | ||||||
| 08/28/2019 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $99.35 | General |
| Category: Immunology | ||||||
| 08/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $102.63 | General |
| Category: RESPIRATORY | ||||||
| 04/24/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $80.13 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: RESPIRATORY | ||||||
| 02/14/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: RESPIRATORY | ||||||
| 02/04/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: RESPIRATORY | ||||||
| 01/02/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $79.08 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $67.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/05/2018 | Fisher & Paykel Healthcare Inc | Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) | Food and Beverage | In-kind items and services | $59.61 | General |
| Category: Respiratory | ||||||
| 06/26/2017 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $71.37 | General |
| Category: Immunology | ||||||
| 06/19/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 02/09/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $107.60 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 15 | 1,047 | 1,124 | $163,704 | $51,445 |
| 2020 | 12 | 1,282 | 1,381 | $152,758 | $56,610 |
Total Patients
2,329
Total Services
2,505
Medicare Billing
$108,055
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 108 | 108 | $26,892 | $12,581 | 46.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 127 | $14,246 | $7,786 | 54.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 47 | 47 | $15,651 | $6,667 | 42.6% |
| 31653 | Examination of lung airways using an endoscope with imaging guidance and ultrasound, 3 or more lymph nodes involved | Facility | 2021 | 25 | 25 | $23,935 | $4,831 | 20.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 89 | $11,926 | $4,824 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 52 | $8,428 | $4,396 | 52.2% |
| 31652 | Examination of lung airways using an endoscope with imaging guidance and ultrasound, 1 or 2 lymph nodes involved | Facility | 2021 | 11 | 11 | $9,591 | $1,922 | 20.0% |
| 31628 | Biopsy of one lobe of lung using an endoscope | Facility | 2021 | 16 | 17 | $11,681 | $1,865 | 16.0% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 154 | 159 | $7,661 | $1,405 | 18.3% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2021 | 13 | 14 | $3,850 | $1,069 | 27.8% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 155 | 160 | $5,694 | $1,048 | 18.4% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2021 | 21 | 21 | $11,091 | $753.04 | 6.8% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 50 | 52 | $3,120 | $676.57 | 21.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 93 | 95 | $3,135 | $600.68 | 19.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 72 | 74 | $3,700 | $531.05 | 14.4% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 24 | 24 | $1,176 | $190.80 | 16.2% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 24 | 24 | $864.00 | $141.40 | 16.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 14 | 14 | $700.00 | $98.04 | 14.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 11 | 11 | $363.00 | $58.50 | 16.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 137 | 137 | $34,113 | $15,279 | 44.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 63 | 63 | $20,979 | $9,782 | 46.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 160 | 186 | $20,460 | $9,508 | 46.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 73 | 134 | $17,956 | $7,479 | 41.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 73 | $11,753 | $5,168 | 44.0% |
| 31653 | Examination of lung airways using an endoscope with imaging guidance and ultrasound | Facility | 2020 | 14 | 14 | $13,454 | $2,775 | 20.6% |
About Dr. Mark Grimm, MD
Dr. Mark Grimm, MD is a Pulmonary Disease healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003967696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Grimm, MD has received a total of $976.79 in payments from pharmaceutical and medical device companies, with $164.29 received in 2021. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($962.90).
As a Medicare-enrolled provider, Grimm has provided services to 2,329 Medicare beneficiaries, totaling 2,505 services with total Medicare billing of $108,055. Data is available for 2 years (2020–2021), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Springfield, MO
- Active Since 01/12/2007
- Last Updated 05/13/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1003967696
Products in Payments
- NUCALA (Biological) $181.71
- TRELEGY ELLIPTA (Drug) $117.41
- BEVESPI AEROSPHERE (Drug) $107.60
- Esbriet (Biological) $99.35
- Xolair (Biological) $71.37
- BREZTRI AEROSPHERE (Drug) $70.85
- AVYCAZ (Drug) $67.27
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $59.61
- STIOLTO RESPIMAT (Drug) $33.62
- LONHALA MAGNAIR (Drug) $33.27
- BREZTRI (Drug) $18.37
- SPIRIVA RESPIMAT (Drug) $13.89
- Prolastin-C Liquid (Biological) $12.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Springfield
Mark Tidswell, Md, MD
Pulmonary Disease — Payments: $144,523
Pulmonary Disease $144,523
David Crabtree, M.d, M.D
Pulmonary Disease — Payments: $15,247
Pulmonary Disease $15,247
Stanley Glasser, Md, MD
Pulmonary Disease — Payments: $13,212
Pulmonary Disease $13,212
David Sotello Aviles, Md, MD
Pulmonary Disease — Payments: $10,086
Pulmonary Disease $10,086
Kvr Mohan Rao, Md, MD
Pulmonary Disease — Payments: $9,161
Pulmonary Disease $9,161
Thirupaimaruth Raman, Md, MD
Pulmonary Disease — Payments: $8,410
Pulmonary Disease $8,410